Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact
D Ennishi, A Mottok, S Ben-Neriah… - Blood, The Journal …, 2017 - ashpublications.org
The clinical significance of MYC and BCL2 genetic alterations in diffuse large B-cell
lymphoma (DLBCL), apart from translocations, has not been comprehensively investigated …
lymphoma (DLBCL), apart from translocations, has not been comprehensively investigated …
Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact
D Ennishi, A Mottok, S Ben-Neriah, HP Shulha… - …, 2017 - okayama.elsevierpure.com
The clinical significance of MYC and BCL2 genetic alterations in diffuse large B-cell
lymphoma (DLBCL), apart from translocations, has not been comprehensively investigated …
lymphoma (DLBCL), apart from translocations, has not been comprehensively investigated …
[引用][C] Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact
D Ennishi, A Mottok, S Ben-Neriah, HP Shulha… - Blood, 2017 - cir.nii.ac.jp
Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific
clinical impact | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
clinical impact | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
[HTML][HTML] Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact
D Ennishi, A Mottok, S Ben-Neriah, HP Shulha… - Blood, 2017 - Elsevier
The clinical significance of MYC and BCL2 genetic alterations in diffuse large B-cell
lymphoma (DLBCL), apart from translocations, has not been comprehensively investigated …
lymphoma (DLBCL), apart from translocations, has not been comprehensively investigated …
Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact.
D Ennishi, A Mottok, S Ben-Neriah, HP Shulha… - Blood, 2017 - europepmc.org
The clinical significance of MYC and BCL2 genetic alterations in diffuse large B-cell
lymphoma (DLBCL), apart from translocations, has not been comprehensively investigated …
lymphoma (DLBCL), apart from translocations, has not been comprehensively investigated …
Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact
D Ennishi, A Mottok, S Ben-Neriah, HP Shulha… - …, 2017 - pubmed.ncbi.nlm.nih.gov
The clinical significance of MYC and BCL2 genetic alterations in diffuse large B-cell
lymphoma (DLBCL), apart from translocations, has not been comprehensively investigated …
lymphoma (DLBCL), apart from translocations, has not been comprehensively investigated …
Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact
D Ennishi, A Mottok, S Ben-Neriah, HP Shulha… - …, 2017 - okayama.elsevierpure.com
抄録 The clinical significance of MYC and BCL2 genetic alterations in diffuse large B-cell
lymphoma (DLBCL), apart from translocations, has not been comprehensively investigated …
lymphoma (DLBCL), apart from translocations, has not been comprehensively investigated …